Valiant Laboratories Ltd - 543998 - Closure of Trading Window
Closure of Trading Window for the quarter and year ended March 31, 2024.27-03-2024
27-03-2024
Valiant Laboratories Ltd - 543998 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Postal Ballot Notice08-03-2024
Valiant Laboratories Ltd - 543998 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Postal Ballot Notice dated February 09, 2024 for approval of Material Related Party Transaction(s).07-03-2024
Valiant Laboratories Ltd - 543998 - Announcement under Regulation 30 (LODR)-Credit Rating
Announcement Under Regulation 30(LODR)- Credit Rating21-02-2024
Valiant Laboratories Ltd - 543998 - Statement Of Deviation Or Variation Of Funds
Statement of Deviation or Variation of funds for the quarter ended December 31, 2023.13-02-2024
Valiant Laboratories Ltd - 543998 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Monitoring Agency Report for the quarter ended December 31, 2023.13-02-2024
Valiant Laboratories Ltd - 543998 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR)- Newspaper Publication of Financial Results for the Quarter and Nine months ended December 31, 2023.11-02-2024
Valiant Laboratories Ltd - 543998 - Financial Results For The Quarter And Nine Months Ended December 31, 2023.
Financial Results for the quarter and nine months ended December 31, 2023.09-02-2024
Valiant Laboratories Ltd - 543998 - Board Meeting Outcome for Outcome Of The Board Meeting
Outcome of the Board Meeting09-02-2024
Valiant Laboratories Ltd - 543998 - Board Meeting Intimation for Audited Financial Results For The Quarter Ended December 31, 2023.
Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 ,inter alia, to consider and approve Audited Financial Results for the Quarter ended December 31, 2023.01-02-2024